Comerica Bank’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Comerica Bank’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,019	Closed	-$266K	–	3824
2025 Q1	$266K	Sell	2,019 -209,111	-99%	-$26.1M	﹤0.01%	2165
2024 Q4	$17.6M	Sell	211,130 -365	-0.2%	-$30K	0.07%	258
2024 Q3	$15.5M	Buy	211,495 +31,715	+18%	+$2.38M	0.06%	312
2024 Q2	$12.3M	Buy	179,780 +174,739	+3,466%	+$12.1M	0.05%	346
2024 Q1	$349K	Buy	5,041 +30	+0.6%	+$2.06K	﹤0.01%	2054
2023 Q4	$359K	Sell	5,011 -881	-15%	-$50.7K	﹤0.01%	2016
2023 Q3	$307K	Buy	+5,892	New	+$343K	﹤0.01%	2027

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Comerica Bank's ITCI Position: Q2 2025 in Review

Comerica Bank sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,019 shares — an estimated $266K sold.

Comerica Bank first reported a position in ITCI in Q3 2023 and held it in 7 quarters. The position peaked at $17.6M in Q4 2024. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Comerica Bank reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Comerica Bank sold 2,019 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $266K.
Comerica Bank first reported a position in Intra-Cellular Therapies Inc. in Q3 2023 and held it in 7 quarters.
Comerica Bank's Intra-Cellular Therapies Inc. position peaked at $17.6M in Q4 2024.
3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Comerica Bank's 13F filing for Q2 2025, filed 14 Aug 2025.